Dec 7, 2018  |  8:00am - 9:00am
Rounds

City-Wide Endocrinology Rounds

Title: "Should Metformin Remain First-Line Therapy?"

Speaker: Dr. Alice Cheng, Staff Endocrinologist, St. Michael's Hospital & Trillium Health Partners; Associate Professor, University of Toronto

Learning Objectives:

At the end of this session, the participant should be able to:

  • Explain the rationale for metformin's current position in the management of T2D
  • Justify alternative options for first-line
  • Decide for yourself what should be first-line

Host: Dr. Jackie James